KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Dr Matteo Lambertini from the Dana-Farber Cancer Institute talks to ecancer about strategies for fertility preservation, knowing that breast cancer is increasing among women who are of reproductive age. He discusses the fact that many patients at the time of breast cancer diagnosis can still decide if they want to have children in the future, and the strategies available to achieve this.
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 11th - 17th, 2023
Rationale for routine use of IORT for early breast cancer and data for specific indications
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis
Low-cost detection and treatment strategies for breast cancer patients in LMICs